During the past decade, Malawi-Liverpool-Wellcome Trust Clinical Research Programme conducted 8 clinical trials. In the 10-year time frame, 8 clinical trials started and 1 clinical trials were completed, i.e. on average, 12.5% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Malawi-Liverpool-Wellcome Trust Clinical Research Programme" #1 sponsor was "Liverpool School of Tropical Medicine" with 2 trials, followed by "London School of Hygiene and Tropical Medicine" with 2 trials sponsored, "Foundation for Innovative New Diagnostics, Switzerland" with 1 trials sponsored, "Murdoch Childrens Research Institute" with 1 trials sponsored and "Queen Mary University of London" with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Malawi-Liverpool-Wellcome Trust Clinical Research Programme" #1 collaborator was "Malawi-Liverpool-Wellcome Trust Clinical Research Programme" with 6 trials as a collaborator, "Kamuzu University of Health Sciences" with 2 trials as a collaborator, "Liverpool School of Tropical Medicine" with 2 trials as a collaborator, "London School of Hygiene and Tropical Medicine" with 2 trials as a collaborator and "University College, London" with 2 trials as a collaborator. Other collaborators include 30 different institutions and companies that were collaborators in the rest 38 trials.

According to Clinical.Site data, the most researched conditions in "Malawi-Liverpool-Wellcome Trust Clinical Research Programme" are "13-valent Pneumococcal Vaccine" (1 trials), "Asthma" (1 trials), "Chronic Lung Disease" (1 trials), "Diagnosis of Tuberculosis in People Living With HIV" (1 trials) and "Diarrhea" (1 trials). Many other conditions were trialed in "Malawi-Liverpool-Wellcome Trust Clinical Research Programme" in a lesser frequency.

Most popular intervention types in "Malawi-Liverpool-Wellcome Trust Clinical Research Programme" are "Other" (4 trials), "Device" (2 trials), "Drug" (2 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "Azithromycin" (2 trials), "Clinic-based ART assessment and initiation" (1 trials), "Fujifilm SILVAMP TB LAM" (1 trials) and "Home assessment and initiation of ART" (1 trials). Other intervention names were less common.

The vast majority of trials in "Malawi-Liverpool-Wellcome Trust Clinical Research Programme" are 9 trials for "All" genders.

Currently, there are NaN active trials in "Malawi-Liverpool-Wellcome Trust Clinical Research Programme". 1 are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 7 completed trials in Malawi-Liverpool-Wellcome Trust Clinical Research Programme, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Malawi-Liverpool-Wellcome Trust Clinical Research Programme, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 3 trials that are defined as “Not Applicable".